Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology

Clinical Trials: Mesothelioma


A listing of clinical trials currently looking for volunteers to enroll in Mesothelioma studies. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Birmingham : University of Alabama at Birmingham

Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901)

California

Corona : Wilshire Oncology Medical Group

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Duarte : City of Hope-Comprehensive Cancer Cente

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Florida

Tampa : H. Lee Moffitt Cancer Center

CRS-207 Cancer Vaccine in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma

Illinois

Elgin : Sherman Health

SWOG S0905 Phase I/II Randomized Study of Pemetrexed Disodium and Cisplatin With Versus Without Cediranib Maleate in Patients With Malignant Pleural Mesothelioma

View More »

Chicago : University of Chicago

An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant Mesothelioma

Maryland

Baltimore : Johns Hopkins

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Bethesda : National Cacner Institue

A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers

Bethesda : National Cancer Institute

CRS-207 Cancer Vaccine in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma

New Jersey

Basking Ridge : Memorial Sloan-Kettering at Basking Ridge

Study Using Chemotherapy +/- Pleurectomy/Decortication Followed By Intensity Modulated Radiation Therapy

New York

Commack : Memorial Sloan-Kettering Cancer Center @ Suffolk

Study Using Chemotherapy +/- Pleurectomy/Decortication Followed By Intensity Modulated Radiation Therapy

New York : New York University Cancer Center

An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant Mesothelioma

New York : Columbia University

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

New York : Memorial Sloan-Kettering Cancer Center

Study Using Chemotherapy +/- Pleurectomy/Decortication Followed By Intensity Modulated Radiation Therapy

Rockville Centre : Memorial Sloan-Kettering at Mercy Medical Center

Study Using Chemotherapy +/- Pleurectomy/Decortication Followed By Intensity Modulated Radiation Therapy

View More »

Sleepy Hollow : Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center

Study Using Chemotherapy +/- Pleurectomy/Decortication Followed By Intensity Modulated Radiation Therapy

Oklahoma

Tennessee

Texas

Dallas : UTsouthwestern medical center

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Houston : Md Anderson Cancer Center

Study Using Chemotherapy +/- Pleurectomy/Decortication Followed By Intensity Modulated Radiation Therapy

Belgium

Antwerpen : UZ Antwerpen

A Study of Cetuximab Combined With Cisplatin or Carboplatin/Pemetrexed as First Line Treatment in Patients With Malignant Pleural Mesothelioma.

Bruxelles : Cliniques Universitarie St. Luc

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Bruxelles : Institut Jules Bordet

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Gent : Universitair Ziekenhuis

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Ghent : University Hospital Ghent

A Study of Cetuximab Combined With Cisplatin or Carboplatin/Pemetrexed as First Line Treatment in Patients With Malignant Pleural Mesothelioma.

View More »

Liège : Centre Hospitalier Universitaire de Liège

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Mechelen : AZ St. Maarten

A Study of Cetuximab Combined With Cisplatin or Carboplatin/Pemetrexed as First Line Treatment in Patients With Malignant Pleural Mesothelioma.

Canada

Edmonton : UAB - Alberta Cancer Board - Cross Cancer Institute

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Toronto : University Health Network, Princess Margaret Hospital

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Toronto : University Health Network

Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma

Egypt

Cairo : National Cancer Institute

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Ireland

Dublin : St James's Hospital

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Italy

Alessandria : Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Alessandria : Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria

Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced Malignant Pleural Mesothelioma

Aviano : Centro di Riferimento Oncologico

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Como : Ospedale Valduce

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Genoa : Istituto Nazionale per la Ricerca sul Cancro

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

View More »

Genova : Asl 3 genovese, Ospedale Villa Scassi

Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced Malignant Pleural Mesothelioma

Milan : Fondazione San Raffaele del Monte Tabor

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Monferrato : Ospedale Santo Spirito

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Monza : Azienda Ospedaliera San Gerardo

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Orbassano : Azienda Ospedaliera Universitaria San Luigi Gonzaga

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Padova : Istituto Oncologico Veneto

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Parma : Azienda Ospedaliero Universitaria di Parma

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Pavia : IRCCS Policlinico S. Matteo

Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced Malignant Pleural Mesothelioma

Rho : A.O. Salvini Garbagnate, Ospedale di Rho

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Rozzano : Istituto Clinico Humanitas

Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced Malignant Pleural Mesothelioma

Siena : Azienda Ospedaliera Senese

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Siena : Medical Oncology and Immunotherapy Unit, University Hospital of Siena

The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma

Treviso : Ospedale Ca' Foncello

Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced Malignant Pleural Mesothelioma

Netherlands

Amsterdam : Antoni van Leeuwenhoekziekenhuis (NKI-AVL)

Axitinib in Malignant Mesothelioma

Harderwijk : St. Jansdal Hospital

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Heerlen : AMC Heerlen

A Study of Cetuximab Combined With Cisplatin or Carboplatin/Pemetrexed as First Line Treatment in Patients With Malignant Pleural Mesothelioma.

Nieuwegein : St. Antonius Hospital

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Poland

Gdansk : Medical University of Gdansk

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Warsaw : Maria Sklodowska Memorial Cancer Center and Institute of Oncology

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

United Kingdom

Cottingham : Castle Hill Hospital

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Glasgow : The Beatson West of Scotland Cancer Centre

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Leicester : University Hospitals of Leicester

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

London : Guy's Hospital

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

London : The Royal Marsden Hospital

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

View More »

Maidstone : Kent Oncology Centre Maidstone Hospital

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Manchester : Chest Clinic, Wythenshawe Hospital

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Middlesex : Mount Vernon Cancer Centre

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Sheffield : Weston Park Hospital, Sheffield Teaching Hospitals NHS Foundation Trust

Intrapleural Administration of HSV1716 to Treat Patients With Malignant Pleural Mesothelioma.

Sutton : The Royal Marsden Hospital

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed